Medical Devices News - Paramount Recruitment

PositiveID has begun a clinical trial of its Easy Check non-invasive breath glucose detection device, intended for use in people with diabetes.

Join leading expert Dr Andrew Feilden at a live webinar, Introduction to Extractables and Leachables, on 21 February.

Second Sight Medical Products' Argus II retinal prosthesis system has demonstrated improvements in blind people suffering from degenerative diseases, such as retinitis pigmentosa.

Boston Scientific has announced the global launch of the Expect 19 flex endoscopic ultrasound aspiration needle, used for acquiring tissue samples under endoscopic ultrasound (EUS) guidance for cancer diagnosis in organs adjacent to the gastrointesti…

InspireMD has reported the top-line clinical results from an investigator-sponsored controlled randomised trial of MGuard conducted in Chile.

Diagnostic Imaging Northwest (DINW) has launched the new extremity 1.5 Tesla MRI scanner GE Optima in the Northwest.

Spectranetics has announced the six month interim results from the Photo-Ablation using the TURBO-Booster and Excimer Laser for In-Stent Restenosis Treatment (PATENT) study.

Signal Genetics, a genetic testing company, has signed an agreement to acquire all the assets of New York based ChipDX, including patents for prognostic tests in lung, breast and colon cancers.

US-based medical device company, Olive Medical, has launched the industry's first surgical camera system to enable surgical imaging at a lower cost.

Boston Scientific has announced the first European patient implant of its Promus Element Plus Stent System at the Columbus and San Raffaele Hospitals in Milan, Italy.

AngioDynamics, a medical device provider, has signed a definitive agreement to acquire global medical device company Navilyst Medical from Avista Capital Partners for around $372m.

The US Food and Drug Administration (FDA) has granted 510(k) clearance for Roche Molecular Diagnostics' cobas CT/NG test, used to detect chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) infections in both symptomatic and asymptomatic patient…

Endologix, a developer and marketer of innovative treatments for aortic disorders, has enrolled the first patient in the company's US clinical trial to evaluate the Ventana fenestrated stent graft system for the endovascular repair of juxtarenal and …

The European commission has granted extended CE Mark approval for two additional sizes of CardioKinetix's Parachute ventricular partitioning device, used to treat patients with heart failure resulting from a heart attack.

US-based early stage biotechnology venture Gamma Therapeutics has signed a manufacturing contract with Zeus Scientific, a manufacturer of autoimmune and infectious disease immunoassay kits and products for the clinical diagnostic industry.